Page last updated: 2024-08-17

tetraethyl lead and TDP-43 Proteinopathies

tetraethyl lead has been researched along with TDP-43 Proteinopathies in 1 studies

*TDP-43 Proteinopathies: Diseases characterized by the presence of abnormally phosphorylated, ubiquitinated, and cleaved DNA-binding protein TDP-43 in affected brain and spinal cord. Inclusions of the pathologic protein in neurons and glia, without the presence of AMYLOID, is the major feature of these conditions, thus making these proteinopathies distinct from most other neurogenerative disorders in which protein misfolding leads to brain amyloidosis. Both frontotemporal lobar degeneration and AMYOTROPHIC LATERAL SCLEROSIS exhibit this common method of pathogenesis and thus they may represent two extremes of a continuous clinicopathological spectrum of one disease. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Deng, Z; Fuller-Thomson, E1

Other Studies

1 other study(ies) available for tetraethyl lead and TDP-43 Proteinopathies

ArticleYear
Could Lifetime Lead Exposure Play a Role in Limbic-predominant Age-related TDP-43 Encephalopathy (LATE)?
    Journal of Alzheimer's disease : JAD, 2020, Volume: 73, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Autopsy; Dementia; DNA-Binding Proteins; Environmental Exposure; Female; Half-Life; Homeostasis; Humans; Lead; Lead Poisoning, Nervous System; Limbic System; Male; Middle Aged; TDP-43 Proteinopathies; Tetraethyl Lead; Tibia

2020